Boston Partners Jazz Pharmaceuticals PLC Transaction History

Boston Partners

$77.6 Billion
Q4 2024

A detailed history of Boston Partners transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Boston Partners holds 9,172 shares of JAZZ stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,172

Previous 9,172 -0.0%

Holding current value

$1.32 Million

Previous $1.02 Million 10.47%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.57 - $116.37 $60,945 - $70,520	606 Added 7.07%	9,172 $1.02 Million
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $65,274 - $74,719	-628 Reduced 6.83%	8,566 $914,000
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $331,171 - $381,713	-2,875 Reduced 23.82%	9,194 $1.11 Million
Q4 2023 Feb 07, 2024	BUY	$114.26 - $136.0 $244,630 - $291,176	2,141 Added 21.57%	12,069 $1.48 Million
Q3 2023 Nov 07, 2023	BUY	$122.0 - $145.31 $405,894 - $483,446	3,327 Added 50.4%	9,928 $1.29 Million
Q1 2023 May 09, 2023	BUY	$133.98 - $160.47 $110,533 - $132,387	825 Added 14.28%	6,601 $965,000
Q4 2022 Feb 07, 2023	BUY	$129.72 - $159.85 $17,252 - $21,260	133 Added 2.36%	5,776 $920,000
Q3 2022 Nov 09, 2022	BUY	$126.59 - $161.18 $14,431 - $18,374	114 Added 2.06%	5,643 $752,000
Q2 2022 Aug 10, 2022	SELL	$141.59 - $168.66 $5.41 Million - $6.44 Million	-38,185 Reduced 87.35%	5,529 $862,000
Q1 2022 May 10, 2022	SELL	$129.64 - $160.7 $67.6 Million - $83.8 Million	-521,660 Reduced 92.27%	43,714 $6.81 Million
Q4 2021 Feb 04, 2022	SELL	$119.87 - $145.67 $531,623 - $646,046	-4,435 Reduced 0.78%	565,374 $72 Million
Q3 2021 Nov 05, 2021	BUY	$128.64 - $184.79 $1.64 Million - $2.36 Million	12,777 Added 2.29%	569,809 $74.2 Million
Q2 2021 Aug 12, 2021	BUY	$160.2 - $186.42 $1.29 Million - $1.5 Million	8,053 Added 1.47%	557,032 $99 Million
Q1 2021 May 10, 2021	SELL	$150.19 - $173.5 $64.3 Million - $74.3 Million	-428,447 Reduced 43.83%	548,979 $90.2 Million
Q4 2020 Feb 04, 2021	BUY	$140.71 - $165.05 $397,365 - $466,101	2,824 Added 0.29%	977,426 $161 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $132,246 - $180,739	-1,254 Reduced 0.13%	974,602 $139 Million
Q2 2020 Aug 12, 2020	SELL	$95.68 - $121.88 $28.9 Million - $36.8 Million	-301,745 Reduced 23.62%	975,856 $108 Million
Q1 2020 May 13, 2020	SELL	$87.74 - $152.74 $5.3 Million - $9.23 Million	-60,461 Reduced 4.52%	1,277,601 $127 Million
Q4 2019 Feb 05, 2020	SELL	$117.65 - $153.73 $3.16 Million - $4.12 Million	-26,820 Reduced 1.97%	1,338,062 $200 Million
Q3 2019 Nov 20, 2019	BUY	$125.18 - $143.24 $3.03 Million - $3.47 Million	24,210 Added 1.81%	1,364,882 $175 Million
Q3 2019 Nov 08, 2019	SELL	$125.18 - $143.24 $43,938 - $50,277	-351 Reduced 0.03%	1,340,672 $191 Million
Q2 2019 Aug 26, 2019	SELL	$125.55 - $144.48 $3,138 - $3,611	-25 Reduced -0.0%	1,341,023 $191 Million
Q2 2019 Aug 09, 2019	BUY	$125.55 - $144.48 $4.44 Million - $5.11 Million	35,385 Added 2.71%	1,341,048 $191 Million
Q1 2019 May 03, 2019	SELL	$121.81 - $142.95 $1.18 Million - $1.39 Million	-9,708 Reduced 0.74%	1,305,663 $187 Million
Q4 2018 Feb 07, 2019	BUY	$115.94 - $166.74 $23 Million - $33.1 Million	198,306 Added 17.75%	1,315,371 $163 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $4.41 Million - $4.95 Million	27,409 Added 2.52%	1,117,065 $188 Million
Q2 2018 Aug 03, 2018	BUY	$146.33 - $183.18 $2.75 Million - $3.45 Million	18,821 Added 1.76%	1,089,656 $188 Million
Q1 2018 May 04, 2018	SELL	$135.59 - $157.16 $17.4 Million - $20.2 Million	-128,353 Reduced 10.7%	1,070,835 $162 Million
Q4 2017 Feb 01, 2018	BUY	$131.06 - $150.39 $157 Million - $180 Million	1,199,188	1,199,188 $161 Million

Others Institutions Holding JAZZ

# of Institutions

544

Shares Held

59M

Call Options Held

125K

Put Options Held

58.4K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $9.04B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account